Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-8,816
Closed -$130K 4460
2025
Q3
$130K Sell
8,816
-1,836
-17% -$18.7K ﹤0.01% 3600
2025
Q2
$105K Buy
+10,652
New +$88.2K ﹤0.01% 3574
2024
Q1
Sell
-12,261
Closed -$137K 4918
2023
Q4
$137K Buy
12,261
+7,077
+137% +$65K ﹤0.01% 4003
2023
Q3
$80K Sell
5,184
-5,348
-51% -$89.8K ﹤0.01% 4055
2023
Q2
$200K Sell
10,532
-38,419
-78% -$675K ﹤0.01% 3421
2023
Q1
$746K Sell
48,951
-12,998
-21% -$169K ﹤0.01% 2468
2022
Q4
$789K Buy
61,949
+39,347
+174% +$354K ﹤0.01% 2433
2022
Q3
$131K Buy
+22,602
New +$99.3K ﹤0.01% 3954

Other funds holding ETNB

Walleye Trading's ETNB Position: Q4 2025 in Review

Walleye Trading sold out of 89bio (ETNB) in Q4 2025, closing a stake of 8,816 shares — an estimated $130K sold.

Walleye Trading first reported a position in ETNB in Q3 2022 and held it in 8 quarters. The position peaked at $789K in Q4 2022. 2 funds tracked by Wall St. Rank hold ETNB as of Q4 2025.

  • Walleye Trading reported no remaining 89bio position as of Q4 2025 after selling out during the quarter.
  • Walleye Trading sold 8,816 89bio shares in Q4 2025, an estimated $130K.
  • Walleye Trading first reported a position in 89bio in Q3 2022 and held it in 8 quarters.
  • Walleye Trading's 89bio position peaked at $789K in Q4 2022.
  • 2 funds tracked by Wall St. Rank held 89bio as of Q4 2025.

Based on Walleye Trading's 13F filing for Q4 2025, filed 13 Feb 2026.